VCCircle | In Conversation With Industry Leaders

In Conversation

Snapdeal will invest $250M in technology and building the brand: Kunal Bahl

The numbers translate into Snapdeal doing around Rs 1,000 crore GMV in the month.

Priyanka Sahay
Realty is yet to be out of slackness but LP sentiments have improved: Amit Goenka

The chief of new realty PE firm Nisus says REITs have been mistimed.

Swet Sarika
Shantha Biotechnics' CEO on rebuilding vaccines business, products & strategy

Acquired by Sanofi, WHO had previously delisted its flagship product but approved it again this year.

Jasleen Kaur Batra
N R Narayana Murthy & Nandan Nilekani reflect on past, present & future of Infosys

Effective today, the co-founders are no longer associated with management of the IT giant.

Vishal Krishna
We will look at ventures looking to raise Series A: Rahul Khanna of Trifecta

The venture debt firm will invest Rs 5-15 crore in a portfolio firm.

Sainul K Abudheen
Launched as a support brand, ethnic beverages now outsell energy drink: Hector CEO

The new plant coming up in Mysore will have a production capacity of 7.5 million bottles a month.

Diksha Dutta
MakeMyTrip's early stage investment fund is an extension to M&A strategy: Magow

MakeMyTrip's strategy is different from Info Edge, which has gone beyond its verticals in external investments.

Sainul K Abudheen
Euphoria of new govt visible in stock market, not real estate: ATS' Getamber Anand

He says PE firms need to make a longer term bet to reap rewards from low-cost housing.

Swet Sarika
Genpact chief on changing contours of the firm, life with Bain as an investor

Tiger says investors like BPO sector as it’s an underpenetrated large market and offers long-term growth.

Diksha Dutta
The worst is over for real estate market: Sobha’s JC Sharma

The firm is projecting sales of around Rs 2,600 crore this fiscal.

Swet Sarika
Piramal’s Khushru Jijina is bullish on realty in FY14-15

Piramal Fund is signing cheques worth Rs 600-800 crore a month.

Swet Sarika
‘We will have the easiest term sheets’: Rehan Yar Khan of Orios Venture Partners

Khan is positioning Orios as an entrepreneur-friendly fund which will not take more than 30 days to write the cheque from the day it meets an entrepreneur.

Sainul K Abudheen
We are in acquisition talks with over 6 startups: Fractal Analytics’ S Velamakanni

TA Associates-backed Fractal competes with Mu Sigma, among others.

Sainul K Abudheen
We will remain asset-light but may own some properties: Fortis’ CEO Aditya Vij

The firm’s focus is on expanding geographically and getting further into specialties, he says.

Jasleen Kaur Batra
We are cash flow intensive and less leveraged: Welspun Renewables’ Vineet Mittal

The chief of the clean energy firm says that the twin PE funding this year would be enough to take the firm to a mature stage.

Anuradha Verma
Acquisitions to drive revenue & product expansion: M Balasubramaniam, CEO, Cura

The chief of the med-tech firm says the market has not grown as expected but will expand exponentially over the next five years.

Jasleen Kaur Batra
CDC aims to have significant LP interest in PE funds it backs: Murugappan

There are too many Indian PE funds without enough track record, he says.

Shruti Ambavat
Budget 2014: Show tight control over fiscal situation, populism, says Chanda Kochhar

Budget would need to provide clarity about the prospective nature of taxation, she says.

PTI
For us, M&As are about calibrated aggression: Ramesh Swaminathan, CFO of Lupin

The finance head of the drugmaker says inorganic growth in the past now contributes a quarter of revenue.

Jasleen Kaur Batra
Cipla New Ventures’ head Chandru Chawla on investment strategy, attractive segments & more

The venture investment arm of Cipla has backed US-based Chase Pharma, Manipal Group-promoted Stempeutics Research besides two biotech companies.

Lohit Jagwani

Pages

Upcoming Events

chinetwork

Copyright © 2014 VCCircle.com.
A property of Mosaic Media Ventures Pvt Ltd.